Maintaining strict environmental conditions is critical in pharmaceutical manufacturing to ensure quality, safety, and compliance. Each dosage form and drug type — beta-lactams, non-beta-lactams, liquids, and injections — has specific environmental, temperature, and humidity requirements.
Below is a detailed area-wise overview.
1. Environmental Control in Beta-lactam Manufacturing
Why?
Beta-lactams (penicillins, cephalosporins, carbapenems) are allergenic and degrade rapidly under moisture. They must be produced in segregated, dedicated facilities.
Key Environmental Conditions:
Facility: Independent building with separate AHU.
Air classification:
General manufacturing → ISO Class 8 (Grade D)
Critical operations (dispensing, filling, milling) → ISO Class 7 (Grade C)
Temperature limit: 18–25°C (best practice ~22°C).
Relative Humidity (RH) limit: ≤40–50% (best practice 35–40%) to reduce hydrolysis.
Pressure differential: Negative compared to adjacent areas.
Impact of Non-compliance:
Allergic reactions due to cross-contamination.
Degradation and potency loss.
Regulatory penalties (FDA/EMA/WHO).
References: WHO TRS 986 Annex 2, EU-GMP Annex 3, Schedule M (India).
2. Environmental Control in Non-beta Drug Manufacturing (Oral Solids)
Why?
Non-beta oral solids (tablets, capsules) are less risky but still require environmental stability to prevent degradation.
Key Environmental Conditions:
Air classification:
General tablet/capsule areas → ISO Class 8 (Grade D)
Granulation, blending, coating → ISO Class 7 (Grade C)
Temperature limit: 20–25°C (usually controlled at ~22°C).
Relative Humidity (RH) limit: 45–55% (some moisture-sensitive drugs may need <40%).
HVAC: Recirculation possible with HEPA filtration.
Impact of Non-compliance:
Product degradation (humidity-sensitive actives).
Microbial growth if RH too high.
Poor tablet compression and coating issues.
References: WHO TRS 1019 Annex 2, US FDA 21 CFR Part 211, Schedule M (India).
3. Environmental Control in Liquid Orals Manufacturing
Why?
Liquids (syrups, suspensions) are highly prone to microbial contamination due to the use of water and sugars.
Key Environmental Conditions:
Air classification:
Compounding areas → ISO Class 8 (Grade D)
Filling & packaging → ISO Class 8 (Grade D)
Temperature limit: 20–25°C (commonly 22–23°C).
Relative Humidity (RH) limit: ≤60% (lower preferred for hygroscopic APIs).
Water quality: Purified Water (PW) or Water for Injection (WFI).
Impact of Non-compliance:
Microbial contamination → spoilage & recalls.
Shortened shelf life due to instability.
References: WHO GMP for Liquids, EU-GMP Part I Chapter 3 & 5, Schedule M.
4. Environmental Control in Sterile Injections (Parenterals)
Why?
Sterile products bypass natural body defenses — requiring highest environmental controls.
Cleanroom Classification (EU-GMP Annex 1, 2022):
Step EU-GMP Grade ISO Equivalent Temp RH
Aseptic filling, open ampoules/vials Grade A ISO 5 20–22°C ≤50%
Background to filling (filling room) Grade B ISO 7 20–22°C ≤50%
Preparation of sterile solution, filtration Grade C ISO 7 20–22°C ≤55%
Support & less critical areas Grade D ISO 8 20–25°C ≤60%
Other Key Requirements:
HEPA filters → ≥99.97% efficiency at 0.3 μm.
Laminar Air Flow (LAF) → 0.36–0.54 m/s airflow.
Pressure differential → +10–15 Pa between rooms of different grades.
Continuous monitoring → Grade A must have real-time particle monitoring.
Impact of Non-compliance:
Severe microbial contamination → sepsis, patient death.
Global recalls, FDA warning letters, plant shutdowns.
References: EU-GMP Annex 1 (2022), US FDA Guidance on Aseptic Processing, PIC/S GMP Guide.
✅ Summary of Temp & RH Limits
Product Type Temp Range RH Limit Notes
Beta-lactams 18–25°C ≤40–50% (best 35–40%) Dedicated, segregated facility
Non-beta (OSD) 20–25°C 45–55% Moisture-sensitive may need <40%
Liquids 20–25°C ≤60% Strict microbial monitoring
Sterile injections 20–22°C ≤50–55% Aseptic areas follow Grade A–D
Conclusion
Environmental conditions in pharma are not just regulatory obligations but critical for product quality and patient safety.
Beta-lactams need segregated low-humidity facilities.
Non-beta OSD require stable temperature and moderate humidity.
Liquids need microbial control with moderate humidity.
Sterile injections demand the highest-grade cleanrooms (A–D).
Non-compliance risks product recalls, patient harm, and regulatory action.
